www.fdanews.com/articles/75692-callisto-pharmaceuticals-announces-completion-of-1-8-million-private-placement-financing
CALLISTO PHARMACEUTICALS ANNOUNCES COMPLETION OF $1.8 MILLION PRIVATE PLACEMENT FINANCING
August 24, 2005
Callisto Pharmaceuticals, Inc. (AMEX:KAL), a developer of novel drug therapies in the fight against hematologic cancers and related diseases, announced today completion of a private placement financing of approximately 1.87 million shares of common stock at a per-share price of $0.97 for aggregate gross proceeds of approximately $1.8 million. The proceeds of the financing, which closed yesterday at 5:00 p.m. EST, will be dedicated to funding the ongoing costs of the Company's R&D operations.
Genetic Engineering News (http://www.genengnews.com/news/bnitem.aspx?name=1040045XSL_NEWSML_TO_NEWSML_WEB.xml)